New Test Program Fast-Tracks Long COVID Treatments

Millions of people living with Long COVID may finally see better treatments thanks to a new program that's solving one of the biggest puzzles in modern medicine.

The PolyBio Research Foundation just launched VIPER, a groundbreaking initiative that will figure out which diagnostic tests actually work for detecting Long COVID. The program started with $1.35 million going to researchers at the University of California San Francisco, with more funding on the way.

Here's why this matters. Scientists have made huge progress understanding Long COVID, but they've hit a wall. Dozens of promising diagnostic tests exist in research labs, but none have been properly validated for doctors to use in clinics. Without reliable tests, doctors can't tell which patients have which type of Long COVID, so they can't match people to the right treatments.

VIPER will compare leading diagnostic tests head-to-head to find out which ones accurately detect the virus lingering in the body and other biological causes of Long COVID. Once doctors have validated tests, they can run smarter clinical trials and develop treatments that target the actual biology causing each patient's symptoms.

Dr. Steven Deeks, a UCSF professor leading the research, saw firsthand how a single test transformed HIV care. "Validated diagnostics will allow us to run smarter, more targeted trials and ultimately deliver effective treatments to patients faster," he said.

The funding came from families personally affected by Long COVID, including the Pagliuca family and Greg and Mindy White. Steve Pagliuca, who founded PagsGroup, called Long COVID "one of the most urgent unmet medical challenges of our time." His family knows this struggle intimately.

The VIPER program is just the first phase of a four-step plan designed to turn laboratory discoveries into treatments patients can actually access. By linking validated diagnostics to clinical trials and drug development, the initiative creates a clear path from science to solution.

Why This Inspires

What makes this story special isn't just the science. It's the coordinated effort to fix a broken system. For years, Long COVID patients have watched promising research collect dust while they continue suffering. This program changes that by building the infrastructure needed to move discoveries out of labs and into doctors' offices.

The model mirrors what worked for HIV, one of medicine's greatest success stories. When researchers developed reliable tests for HIV, everything else followed: better trials, targeted therapies, and ultimately, transformed lives.

Now that same systematic approach is coming to Long COVID, backed by families who refuse to watch their loved ones wait any longer.

Real help is on the way for millions waiting for answers.